Global Alectinib Market Growth 2025-2031

December 2025 | 83 pages | ID: GDBEAEA6782EN
LP Information

Abstracts

The global Alectinib market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Alectinib is a medication that belongs to a class of drugs called kinase inhibitors. It is used to treat a type of lung cancer called non-small cell lung cancer (NSCLC) that has a specific genetic mutation called ALK. Alectinib works by blocking the activity of the ALK protein, which helps cancer cells grow and spread. Alectinib can be used as a first-line treatment or after other treatments have failed.

The future market trends of Alectinib are expected to be positive, as the demand for effective and targeted therapies for lung cancer is increasing. Alectinib has shown superior efficacy and safety compared to other ALK inhibitors, such as crizotinib, especially in preventing or delaying brain metastases, which are common in ALK-positive NSCLC patients. Moreover, Alectinib is being investigated for other indications and combinations, such as ALK-positive anaplastic large cell lymphoma, ROS1-positive NSCLC, and Alectinib plus bevacizumab. These factors are likely to boost the market growth of Alectinib in the coming years.

LP Information, Inc. (LPI) ' newest research report, the “Alectinib Industry Forecast” looks at past sales and reviews total world Alectinib sales in 2024, providing a comprehensive analysis by region and market sector of projected Alectinib sales for 2025 through 2031. With Alectinib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Alectinib industry.

This Insight Report provides a comprehensive analysis of the global Alectinib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Alectinib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Alectinib market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Alectinib and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Alectinib.

This report presents a comprehensive overview, market shares, and growth opportunities of Alectinib market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 150mg*140 Capsules
• 150mg*28 Capsules
• 20mg*1 Capsule
• 40mg*1 Capsule
• 150mg*26 Capsules

Segmentation by Application:

• Unresectable NSCLC
• Advanced NSCLC
• Recurrent NSCLC
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Roche
• Everest Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Alectinib market?

What factors are driving Alectinib market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Alectinib market opportunities vary by end market size?

How does Alectinib break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Alectinib Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Alectinib by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Alectinib by Country/Region, 2020, 2024 & 2031
2.2 Alectinib Segment by Type
  2.2.1 150mg*140 Capsules
  2.2.2 150mg*28 Capsules
  2.2.3 20mg*1 Capsule
  2.2.4 40mg*1 Capsule
  2.2.5 150mg*26 Capsules
2.3 Alectinib Sales by Type
  2.3.1 Global Alectinib Sales Market Share by Type (2020-2025)
  2.3.2 Global Alectinib Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Alectinib Sale Price by Type (2020-2025)
2.4 Alectinib Segment by Application
  2.4.1 Unresectable NSCLC
  2.4.2 Advanced NSCLC
  2.4.3 Recurrent NSCLC
  2.4.4 Others
2.5 Alectinib Sales by Application
  2.5.1 Global Alectinib Sale Market Share by Application (2020-2025)
  2.5.2 Global Alectinib Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Alectinib Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Alectinib Breakdown Data by Company
  3.1.1 Global Alectinib Annual Sales by Company (2020-2025)
  3.1.2 Global Alectinib Sales Market Share by Company (2020-2025)
3.2 Global Alectinib Annual Revenue by Company (2020-2025)
  3.2.1 Global Alectinib Revenue by Company (2020-2025)
  3.2.2 Global Alectinib Revenue Market Share by Company (2020-2025)
3.3 Global Alectinib Sale Price by Company
3.4 Key Manufacturers Alectinib Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Alectinib Product Location Distribution
  3.4.2 Players Alectinib Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ALECTINIB BY GEOGRAPHIC REGION

4.1 World Historic Alectinib Market Size by Geographic Region (2020-2025)
  4.1.1 Global Alectinib Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Alectinib Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Alectinib Market Size by Country/Region (2020-2025)
  4.2.1 Global Alectinib Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Alectinib Annual Revenue by Country/Region (2020-2025)
4.3 Americas Alectinib Sales Growth
4.4 APAC Alectinib Sales Growth
4.5 Europe Alectinib Sales Growth
4.6 Middle East & Africa Alectinib Sales Growth

5 AMERICAS

5.1 Americas Alectinib Sales by Country
  5.1.1 Americas Alectinib Sales by Country (2020-2025)
  5.1.2 Americas Alectinib Revenue by Country (2020-2025)
5.2 Americas Alectinib Sales by Type (2020-2025)
5.3 Americas Alectinib Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Alectinib Sales by Region
  6.1.1 APAC Alectinib Sales by Region (2020-2025)
  6.1.2 APAC Alectinib Revenue by Region (2020-2025)
6.2 APAC Alectinib Sales by Type (2020-2025)
6.3 APAC Alectinib Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Alectinib by Country
  7.1.1 Europe Alectinib Sales by Country (2020-2025)
  7.1.2 Europe Alectinib Revenue by Country (2020-2025)
7.2 Europe Alectinib Sales by Type (2020-2025)
7.3 Europe Alectinib Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Alectinib by Country
  8.1.1 Middle East & Africa Alectinib Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Alectinib Revenue by Country (2020-2025)
8.2 Middle East & Africa Alectinib Sales by Type (2020-2025)
8.3 Middle East & Africa Alectinib Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Alectinib
10.3 Manufacturing Process Analysis of Alectinib
10.4 Industry Chain Structure of Alectinib

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Alectinib Distributors
11.3 Alectinib Customer

12 WORLD FORECAST REVIEW FOR ALECTINIB BY GEOGRAPHIC REGION

12.1 Global Alectinib Market Size Forecast by Region
  12.1.1 Global Alectinib Forecast by Region (2026-2031)
  12.1.2 Global Alectinib Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Alectinib Forecast by Type (2026-2031)
12.7 Global Alectinib Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Roche
  13.1.1 Roche Company Information
  13.1.2 Roche Alectinib Product Portfolios and Specifications
  13.1.3 Roche Alectinib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Roche Main Business Overview
  13.1.5 Roche Latest Developments
13.2 Everest Pharmaceuticals
  13.2.1 Everest Pharmaceuticals Company Information
  13.2.2 Everest Pharmaceuticals Alectinib Product Portfolios and Specifications
  13.2.3 Everest Pharmaceuticals Alectinib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Everest Pharmaceuticals Main Business Overview
  13.2.5 Everest Pharmaceuticals Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Alectinib Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Alectinib Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 150mg*140 Capsules
Table 4. Major Players of 150mg*28 Capsules
Table 5. Major Players of 20mg*1 Capsule
Table 6. Major Players of 40mg*1 Capsule
Table 7. Major Players of 150mg*26 Capsules
Table 8. Global Alectinib Sales by Type (2020-2025) & (K Pcs)
Table 9. Global Alectinib Sales Market Share by Type (2020-2025)
Table 10. Global Alectinib Revenue by Type (2020-2025) & ($ million)
Table 11. Global Alectinib Revenue Market Share by Type (2020-2025)
Table 12. Global Alectinib Sale Price by Type (2020-2025) & (USD/Pcs)
Table 13. Global Alectinib Sale by Application (2020-2025) & (K Pcs)
Table 14. Global Alectinib Sale Market Share by Application (2020-2025)
Table 15. Global Alectinib Revenue by Application (2020-2025) & ($ million)
Table 16. Global Alectinib Revenue Market Share by Application (2020-2025)
Table 17. Global Alectinib Sale Price by Application (2020-2025) & (USD/Pcs)
Table 18. Global Alectinib Sales by Company (2020-2025) & (K Pcs)
Table 19. Global Alectinib Sales Market Share by Company (2020-2025)
Table 20. Global Alectinib Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Alectinib Revenue Market Share by Company (2020-2025)
Table 22. Global Alectinib Sale Price by Company (2020-2025) & (USD/Pcs)
Table 23. Key Manufacturers Alectinib Producing Area Distribution and Sales Area
Table 24. Players Alectinib Products Offered
Table 25. Alectinib Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Alectinib Sales by Geographic Region (2020-2025) & (K Pcs)
Table 29. Global Alectinib Sales Market Share Geographic Region (2020-2025)
Table 30. Global Alectinib Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Alectinib Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Alectinib Sales by Country/Region (2020-2025) & (K Pcs)
Table 33. Global Alectinib Sales Market Share by Country/Region (2020-2025)
Table 34. Global Alectinib Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Alectinib Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Alectinib Sales by Country (2020-2025) & (K Pcs)
Table 37. Americas Alectinib Sales Market Share by Country (2020-2025)
Table 38. Americas Alectinib Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Alectinib Sales by Type (2020-2025) & (K Pcs)
Table 40. Americas Alectinib Sales by Application (2020-2025) & (K Pcs)
Table 41. APAC Alectinib Sales by Region (2020-2025) & (K Pcs)
Table 42. APAC Alectinib Sales Market Share by Region (2020-2025)
Table 43. APAC Alectinib Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Alectinib Sales by Type (2020-2025) & (K Pcs)
Table 45. APAC Alectinib Sales by Application (2020-2025) & (K Pcs)
Table 46. Europe Alectinib Sales by Country (2020-2025) & (K Pcs)
Table 47. Europe Alectinib Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Alectinib Sales by Type (2020-2025) & (K Pcs)
Table 49. Europe Alectinib Sales by Application (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Alectinib Sales by Country (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Alectinib Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Alectinib Sales by Type (2020-2025) & (K Pcs)
Table 53. Middle East & Africa Alectinib Sales by Application (2020-2025) & (K Pcs)
Table 54. Key Market Drivers & Growth Opportunities of Alectinib
Table 55. Key Market Challenges & Risks of Alectinib
Table 56. Key Industry Trends of Alectinib
Table 57. Alectinib Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Alectinib Distributors List
Table 60. Alectinib Customer List
Table 61. Global Alectinib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 62. Global Alectinib Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Alectinib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 64. Americas Alectinib Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Alectinib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 66. APAC Alectinib Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Alectinib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Europe Alectinib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Alectinib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 70. Middle East & Africa Alectinib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Alectinib Sales Forecast by Type (2026-2031) & (K Pcs)
Table 72. Global Alectinib Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Alectinib Sales Forecast by Application (2026-2031) & (K Pcs)
Table 74. Global Alectinib Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Roche Basic Information, Alectinib Manufacturing Base, Sales Area and Its Competitors
Table 76. Roche Alectinib Product Portfolios and Specifications
Table 77. Roche Alectinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Roche Main Business
Table 79. Roche Latest Developments
Table 80. Everest Pharmaceuticals Basic Information, Alectinib Manufacturing Base, Sales Area and Its Competitors
Table 81. Everest Pharmaceuticals Alectinib Product Portfolios and Specifications
Table 82. Everest Pharmaceuticals Alectinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Everest Pharmaceuticals Main Business
Table 84. Everest Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Alectinib
Figure 2. Alectinib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Alectinib Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Alectinib Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Alectinib Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Alectinib Sales Market Share by Country/Region (2024)
Figure 10. Alectinib Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 150mg*140 Capsules
Figure 12. Product Picture of 150mg*28 Capsules
Figure 13. Product Picture of 20mg*1 Capsule
Figure 14. Product Picture of 40mg*1 Capsule
Figure 15. Product Picture of 150mg*26 Capsules
Figure 16. Global Alectinib Sales Market Share by Type in 2025
Figure 17. Global Alectinib Revenue Market Share by Type (2020-2025)
Figure 18. Alectinib Consumed in Unresectable NSCLC
Figure 19. Global Alectinib Market: Unresectable NSCLC (2020-2025) & (K Pcs)
Figure 20. Alectinib Consumed in Advanced NSCLC
Figure 21. Global Alectinib Market: Advanced NSCLC (2020-2025) & (K Pcs)
Figure 22. Alectinib Consumed in Recurrent NSCLC
Figure 23. Global Alectinib Market: Recurrent NSCLC (2020-2025) & (K Pcs)
Figure 24. Alectinib Consumed in Others
Figure 25. Global Alectinib Market: Others (2020-2025) & (K Pcs)
Figure 26. Global Alectinib Sale Market Share by Application (2024)
Figure 27. Global Alectinib Revenue Market Share by Application in 2025
Figure 28. Alectinib Sales by Company in 2025 (K Pcs)
Figure 29. Global Alectinib Sales Market Share by Company in 2025
Figure 30. Alectinib Revenue by Company in 2025 ($ millions)
Figure 31. Global Alectinib Revenue Market Share by Company in 2025
Figure 32. Global Alectinib Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Alectinib Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Alectinib Sales 2020-2025 (K Pcs)
Figure 35. Americas Alectinib Revenue 2020-2025 ($ millions)
Figure 36. APAC Alectinib Sales 2020-2025 (K Pcs)
Figure 37. APAC Alectinib Revenue 2020-2025 ($ millions)
Figure 38. Europe Alectinib Sales 2020-2025 (K Pcs)
Figure 39. Europe Alectinib Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Alectinib Sales 2020-2025 (K Pcs)
Figure 41. Middle East & Africa Alectinib Revenue 2020-2025 ($ millions)
Figure 42. Americas Alectinib Sales Market Share by Country in 2025
Figure 43. Americas Alectinib Revenue Market Share by Country (2020-2025)
Figure 44. Americas Alectinib Sales Market Share by Type (2020-2025)
Figure 45. Americas Alectinib Sales Market Share by Application (2020-2025)
Figure 46. United States Alectinib Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Alectinib Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Alectinib Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Alectinib Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Alectinib Sales Market Share by Region in 2025
Figure 51. APAC Alectinib Revenue Market Share by Region (2020-2025)
Figure 52. APAC Alectinib Sales Market Share by Type (2020-2025)
Figure 53. APAC Alectinib Sales Market Share by Application (2020-2025)
Figure 54. China Alectinib Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Alectinib Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Alectinib Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Alectinib Revenue Growth 2020-2025 ($ millions)
Figure 58. India Alectinib Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Alectinib Revenue Growth 2020-2025 ($ millions)
Figure 60. China Taiwan Alectinib Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Alectinib Sales Market Share by Country in 2025
Figure 62. Europe Alectinib Revenue Market Share by Country (2020-2025)
Figure 63. Europe Alectinib Sales Market Share by Type (2020-2025)
Figure 64. Europe Alectinib Sales Market Share by Application (2020-2025)
Figure 65. Germany Alectinib Revenue Growth 2020-2025 ($ millions)
Figure 66. France Alectinib Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Alectinib Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Alectinib Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Alectinib Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Alectinib Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Alectinib Sales Market Share by Type (2020-2025)
Figure 72. Middle East & Africa Alectinib Sales Market Share by Application (2020-2025)
Figure 73. Egypt Alectinib Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Alectinib Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Alectinib Revenue Growth 2020-2025 ($ millions)
Figure 76. Turkey Alectinib Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Alectinib Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Alectinib in 2025
Figure 79. Manufacturing Process Analysis of Alectinib
Figure 80. Industry Chain Structure of Alectinib
Figure 81. Channels of Distribution
Figure 82. Global Alectinib Sales Market Forecast by Region (2026-2031)
Figure 83. Global Alectinib Revenue Market Share Forecast by Region (2026-2031)
Figure 84. Global Alectinib Sales Market Share Forecast by Type (2026-2031)
Figure 85. Global Alectinib Revenue Market Share Forecast by Type (2026-2031)
Figure 86. Global Alectinib Sales Market Share Forecast by Application (2026-2031)
Figure 87. Global Alectinib Revenue Market Share Forecast by Application (2026-2031)